Antibodies
10 July 2024
Kiniksa Pharmaceuticals Commences Enrollment in Abiprubart Phase 2b Clinical Trial in Sjögren’s Disease3 July 2024
Checkpoint Therapeutics Announces Biologics License Application Resubmission for Cosibelimab1 July 2024
Sipavibart EMA regulatory submission accepted under accelerated assessment for COVID-19 prevention27 June 2024
AbbVie Acquires Celsius TherapeuticsNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
SubscribeNewsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
SubscribeFeatured reports